NYSE:SYK - Stryker Stock Price, Forecast & News

Stryker trades on the New York Stock Exchange (NYSE) under the ticker symbol "SYK."

Stryker declared a quarterly dividend on Thursday, December 5th. Shareholders of record on Tuesday, December 31st will be given a dividend of $0.575 per share on Friday, January 31st. This represents a $2.30 annualized dividend and a dividend yield of 1.06%. The ex-dividend date of this dividend is Monday, December 30th. This is an increase from Stryker's previous quarterly dividend of $0.52. View Stryker's Dividend History.

Stryker Co. (NYSE:SYK) posted its earnings results on Tuesday, October, 29th. The medical technology company reported $1.91 EPS for the quarter, topping analysts' consensus estimates of $1.90 by $0.01. The medical technology company earned $3.59 billion during the quarter, compared to analysts' expectations of $3.58 billion. Stryker had a net margin of 23.55% and a return on equity of 25.33%. The firm's revenue was up 10.6% compared to the same quarter last year. During the same quarter in the prior year, the business posted $1.69 EPS. View Stryker's Earnings History.

Stryker is scheduled to release their next quarterly earnings announcement on Tuesday, January 28th 2020. View Earnings Estimates for Stryker.

Stryker will be holding an earnings conference call on Tuesday, January 28th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

Stryker issued an update on its fourth quarter earnings guidance on Tuesday, October, 29th. The company provided earnings per share (EPS) guidance of $2.43 to $2.48 for the period, compared to the Thomson Reuters consensus EPS estimate of $2.45.

20 brokerages have issued 1-year price targets for Stryker's stock. Their forecasts range from $179.00 to $245.00. On average, they anticipate Stryker's share price to reach $222.56 in the next year. This suggests a possible upside of 2.5% from the stock's current price. View Analyst Price Targets for Stryker.

20 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Stryker in the last year. There are currently 6 hold ratings and 14 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Stryker.

News coverage about SYK stock has trended somewhat negative on Thursday, InfoTrie reports. The research firm ranks the sentiment of press coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Stryker earned a coverage optimism score of -1.0 on InfoTrie's scale. They also gave news headlines about the medical technology company a news buzz of 3.0 out of 10, indicating that recent press coverage is unlikely to have an effect on the company's share price in the near future. View News Stories for Stryker.

Stryker saw a increase in short interest in December. As of December 31st, there was short interest totalling 3,910,000 shares, an increase of 10.8% from the December 15th total of 3,530,000 shares. Based on an average trading volume of 1,380,000 shares, the days-to-cover ratio is presently 2.8 days. Approximately 1.1% of the shares of the stock are sold short. View Stryker's Current Options Chain.

Some companies that are related to Stryker include Medtronic (MDT), Abbott Laboratories (ABT), Becton Dickinson and (BDX), Intuitive Surgical (ISRG), Boston Scientific (BSX), Edwards Lifesciences (EW), Baxter International (BAX), IDEXX Laboratories (IDXX), ResMed (RMD), DexCom (DXCM), Teleflex (TFX), Hologic (HOLX), Varian Medical Systems (VAR), Steris (STE) and Insulet (PODD).

Based on aggregate information from My MarketBeat watchlists, some companies that other Stryker investors own include Johnson & Johnson (JNJ), Visa (V), AbbVie (ABBV), Home Depot (HD), Abbott Laboratories (ABT), Walt Disney (DIS), Medtronic (MDT), CVS Health (CVS), NVIDIA (NVDA) and Bank of America (BAC).

Stryker's stock is owned by many different of retail and institutional investors. Top institutional shareholders include Loring Wolcott & Coolidge Fiduciary Advisors LLP MA (0.34%), Fenimore Asset Management Inc. (0.14%), Welch & Forbes LLC (0.14%), Boston Trust Walden Corp (0.10%), Commerzbank Aktiengesellschaft FI (0.09%) and PGGM Investments (0.08%). Company insiders that own Stryker stock include Allan C Golston, Bijoy Sagar, David Floyd, Glenn S Boehnlein, Graham A Mclean, Howard E Cox Jr, Katherine Ann Owen, Kevin Lobo, Lonny J Carpenter, Louise Francesconi, M Kathryn Fink, Michael Damon Hutchinson, Roch Doliveux, Srikant M Datar, Timothy J Scannell, William E Berry Jr and Yin C Becker. View Institutional Ownership Trends for Stryker.

SYK stock was sold by a variety of institutional investors in the last quarter, including Meag Munich Ergo Kapitalanlagegesellschaft MBH, Zurcher Kantonalbank Zurich Cantonalbank, Tandem Investment Advisors Inc., OLD National Bancorp IN, Norris Perne & French LLP MI, Huntington National Bank, State of Alaska Department of Revenue and Farmers & Merchants Investments Inc.. Company insiders that have sold Stryker company stock in the last year include Allan C Golston, Bijoy Sagar, Glenn S Boehnlein, Katherine Ann Owen, Kevin Lobo, Louise Francesconi, M Kathryn Fink, Michael Damon Hutchinson, Srikant M Datar, Timothy J Scannell and Yin C Becker. View Insider Buying and Selling for Stryker.

SYK stock was acquired by a variety of institutional investors in the last quarter, including PGGM Investments, Commerzbank Aktiengesellschaft FI, Empire Life Investments Inc., Johanson Financial Advisors Inc., LVM Capital Management Ltd. MI, Abner Herrman & Brock LLC, GPM Growth Investors Inc. and Fenimore Asset Management Inc.. View Insider Buying and Selling for Stryker.

Shares of SYK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of SYK stock can currently be purchased for approximately $217.07.

Stryker has a market capitalization of $81.21 billion and generates $13.60 billion in revenue each year. The medical technology company earns $3.55 billion in net income (profit) each year or $7.31 on an earnings per share basis. Stryker employs 36,000 workers across the globe.View Additional Information About Stryker.

The official website for Stryker is http://www.strykercorp.com/.

Stryker's mailing address is 2825 AIRVIEW BLVD, KALAMAZOO MI, 49002. The medical technology company can be reached via phone at 269-389-2600 or via email at [email protected]